-transparent.png){kind=logo}
A human monoclonal IgM rheumatoid factor (RF) produced in vitro by an Epstein-Barr virus (EBV)-immortalized cell line was purified by protein A-Sepharose adsorption and coupled by the chromic chloride method to human erythrocytes. The RF-coupled cells were incorporated in reverse passive haemagglutination (RPH) assays to detect immune complexes (IC) using heat-aggregated human IgG as a model system. The sensitivity of the RPH was comparable to an enzyme-linked immunosorbent assay (ELISA) using sheep C1q for the detection of ICs.
Related Publications
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
January 1980,
Journal of immunological methods,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
July 1998,
Artificial cells, blood substitutes, and immobilization biotechnology,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
January 1979,
Journal of immunological methods,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
June 1987,
Arerugi = [Allergy],
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
January 1996,
Developments in biological standardization,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
March 2003,
The Journal of communicable diseases,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
June 1981,
Clinical and experimental immunology,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
September 1981,
Inflammation,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
September 1982,
Arthritis and rheumatism,
C J Welsh, and
M Steinitz, and
M R Clark, and
R R Coombs
January 1980,
Journal of immunological methods,
